Michael L. Avaricio, MD
Specialist
- Medicare participating
At a glance
- Medical school
- Icahn School of Medicine at Mount Sinai (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 351
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Icahn School of Medicine at Mount Sinai
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Specialist primary
NY license 222928 -
Cardiovascular Disease Physician
FL license ME165993 -
Internal Medicine Physician
FL license ME165993
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Advanced Cardiovascular Care PLLC (2 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 351
- Services billed
- 3,400
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 654 | 284 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 431 | 281 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 316 | 271 |
| Ultrasound of both sides of head and neck blood flow | 304 | 268 |
| Ultrasound of leg arteries or artery grafts | 289 | 257 |
| Ultrasound study of arm and leg arteries | 150 | 145 |
| Ultrasound of heart blood flow, valves and chambers | 111 | 108 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 111 | 108 |
| Ultrasound of heart during rest, exercise and/or drug-induced stress with report | 111 | 108 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 111 | 108 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 18 companies reported 66 payments worth $1,525 in total to this clinician.
| Alnylam Pharmaceuticals Inc. | $254 |
|---|---|
| Bayer HealthCare Pharmaceuticals Inc. | $232 |
| Merck Sharp & Dohme LLC | $203 |
| AstraZeneca Pharmaceuticals LP | $203 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $101 |
| Esperion Therapeutics, Inc. | $74.58 |
| E.r. Squibb & Sons, L.l.c. | $72.85 |
| Phathom Pharmaceuticals, Inc. | $56.31 |
| Food and Beverage | $1,525 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $334 in research payments for these studies, mostly to the institutions running them.
- Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)
Cvrx, Inc. · Terminated · NCT04502316
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.